MC1R and NR4A receptors in cellular stress and DNA repair: Implications for UVR protection

Experimental Dermatology

Volumn 23, Issue 7, 2014, Pages 449-452

  Yin, Kelvin ^a   Sturm, Richard A ^a   Smith, Aaron G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

DNA repair; MC1R; NR4A2; UVR

Indexed keywords

BINDING PROTEIN; HISTONE H2AX; MELANOCORTIN 1 RECEPTOR; ORPHAN NUCLEAR RECEPTOR; PROTEIN NR4A; PROTEIN P53; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; DNA; G PROTEIN COUPLED RECEPTOR; NR4A2 PROTEIN, HUMAN; NUCLEAR RECEPTOR RELATED FACTOR 1;

ARTICLE; BASAL CELL CARCINOMA; CELL PROTECTION; CELL STRESS; CELLULAR STRESS RESPONSE; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; GAMMA IRRADIATION; GENETIC TRANSCRIPTION; HOMOLOGOUS RECOMBINATION; HUMAN; MELANOCYTE; MELANOGENESIS; MELANOMA; NON MELANOMA SKIN CANCER; NONHUMAN; RADIATION INJURY; RADIATION PROTECTION; RECOMBINATION REPAIR; SIGNAL TRANSDUCTION; SKIN INJURY; SKIN PROTECTION; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNLIGHT; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; LIGHT; METABOLISM; RADIATION RESPONSE; SKIN NEOPLASMS; ULTRAVIOLET RADIATION;

DNA; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIGHT; MELANOCYTES; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84904380565     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12420     Document Type: Article

References (48)

1. Hadshiew I M, Eller M S, Gilchrest B A. Am J Contact Dermat 2000: 11: 19-25.
2. Hauser J E, Kadekaro A L, Kavanagh R J et al. Pigment Cell Res 2006: 19: 303-314.
3. Cadet J, Douki T. J Invest Dermatol 2011: 131: 1005-1007.
4. Greinert R, Volkmer B, Henning S et al. Nucleic Acids Res 2012: 40: 10263-10273.
5. Kunisada M, Sakumi K, Tominaga Y et al. Cancer Res 2005: 65: 6006-6010.
6. Yeh J I, Levine A S, Du S et al. Proc Natl Acad Sci USA 2012: 109: E2737-E2746.
7. Oh K S, Imoto K, Boyle J et al. DNA Repair 2007: 6: 1359-1370.
8. Povey J E, Darakhshan F, Robertson K et al. Carcinogenesis 2007: 28: 1087-1093.
9. Moser J, Kool H, Giakzidis I et al. Mol Cell 2007: 27: 311-323.
10. DiGiovanna J J, Kraemer K H. J Invest Dermatol 2012: 132: 785-796.
11. Schreiber V, Ame J C, Dolle P et al. J Biol Chem 2002: 277: 23028-23036.
12. Allinson S L, Dianova I I, Dianov G L. Acta Biochim Pol 2003: 50: 169-179.
13. Aylon Y, Kupiec M. Cell Cycle 2005: 4: 259-261.
14. Dronkert M L, Beverloo H B, Johnson R D et al. Mol Cell Biol 2000: 20: 3147-3156.
15. Lim Y C, Roberts T L, Day B W et al. Mol Cancer Ther 2012: 11: 1863-1872.
16. Cui R, Widlund H R, Feige E et al. Cell 2007: 128: 853-864.
17. Slominski A, Tobin D J, Paus R. Pigment Cell Res 2007: 20: 307-308; author reply 309-310.
18. Newton R A, Smit S E, Barnes C C et al. Peptides 2005: 26: 1818-1824.
19. Gerstenblith M R, Goldstein A M, Fargnoli M C et al. Hum Mutat 2007: 28: 495-505.
20. Beaumont K A, Liu Y Y, Sturm R A. Progress Mol Biol Transl Sci 2009: 88: 85-153.
21. Robinson S, Dixon S, August S et al. J Invest Dermatol 2010: 130: 1904-1913.
22. Kadekaro A L, Leachman S, Kavanagh R J et al. FASEB J 2010: 24: 3850-3860.
23. Bohm M, Wolff I, Scholzen T E et al. J Biol Chem 2005: 280: 5795-5802.
24. Kadekaro A L, Kavanagh R, Kanto H et al. Cancer Res 2005: 65: 4292-4299.
25. Song X, Mosby N, Yang J et al. Pigment Cell Melanoma Res 2009: 22: 809-818.
26. Maresca V, Flori E, Bellei B et al. Pigment Cell Melanoma Res 2010: 23: 263-275.
27. Corre S, Primot A, Sviderskaya E et al. J Biol Chem 2004: 279: 51226-51233.
28. Newton R A, Roberts D W, Leonard J H et al. Peptides 2007: 28: 2387-2396.
29. Wong S S, Ainger S A, Leonard J H et al. J Invest Dermatol 2012: 132: 1452-1461.
30. Kadekaro A L, Chen J, Yang J et al. Mol Cancer Res 2012: 10: 778-786.
31. Smith A G, Luk N, Newton R A et al. J Biol Chem 2008: 283: 12564-12570.
32. Cao J, Wan L, Hacker E et al. Mol Cell 2013: 51: 409-422.
33. Pearen M A, Muscat G E. Mol Endocrinol 2010: 24: 1891-1903.
34. Maira M, Martens C, Batsche E et al. Mol Cell Biol 2003: 23: 763-776.
35. Zetterstrom R H, Solomin L, Jansson L et al. Science 1997: 276: 248-250.
36. Glass C K, Rosenfeld M G. Genes Dev 2000: 14: 121-141.
37. Saijo K, Winner B, Carson C T et al. Cell 2009: 137: 47-59.
38. Volakakis N, Malewicz M, Kadkhodai B et al. J Mol Endocrinol 2006: 37: 317-326.
39. Wang Z, Benoit G, Liu J et al. Nature 2003: 423: 555-560.
40. Ramirez-Herrick A M, Mullican S E, Sheehan A M et al. Blood 2011: 117: 2681-2690.
41. Malewicz M, Kadkhodaei B, Kee N et al. Genes Dev 2011: 25: 2031-2040.
42. de Leseleuc L, Denis F. Exp Cell Res 2006: 312: 1507-1513.
43. Jagirdar K, Yin K, Harrison M et al. PLoS One 2013: 8: e78075.
44. Gurnell M, Wentworth J M, Agostini M et al. J Biol Chem 2000: 275: 5754-5759.
45. Amouroux R, Campalans A, Epe B et al. Nucleic Acids Res 2010: 38: 2878-2890.
46. Yu S R, Teng Y M, Waters R et al. PLoS Genet 2011: 7: e1002124.
47. Johannessen C M, Johnson L A, Piccioni F et al. Nature 2013: 504: 138-142.
48. Boakye C H, Doddapaneni R, Shah P P et al. PLoS One 2013: 8: e69519.